Adenocarcinoma of Lung, Stage IV Completed Phase 2 Trials for Paclitaxel (DB01229)

Also known as: Adenocarcinoma of Lung Stage IV / Lung adenocarcinoma stage IV / Adenocarcinoma Lung Stage IV / Stage IV Lung Adenocarcinoma / Lung adenocarcinoma metastatic / Adenocarcinoma of lung, stage IV (disorder)

IndicationStatusPhase
DBCOND0087327 (Adenocarcinoma of Lung, Stage IV)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04310943Efficacy and Safety of Tislelizumab Combined With Bevacizumab and Albumin Paclitaxel in Lung AdenocarcinomaTreatment